INmune Bio (INMB) Free Cash Flow (2018 - 2026)
INmune Bio (INMB) free cash flow from Mar 31, 2018 to Mar 31, 2026. The TTM INmune Bio (INMB) free cash flow is -$20M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
INmune Bio (INMB) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -38.28% |
| 3 Years TTM | +10.51% |
| 5 Years TTM | +9.20% |
| All Time TTM | +30.57% |
Annual Free Cash Flow change of INmune Bio (INMB)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$3.40M | -85.61% |
| 2025 | -$24M | -29.20% |
| 2024 | -$33M | +178.46% |
| 2023 | -$12M | -47.20% |
| 2022 | -$23M | -20.39% |
| 2021 | -$29M | +218.79% |
| 2020 | -$8.94M | +66.17% |
| 2019 | -$5.38M | +161.17% |
| 2018 | -$2.06M | +171.05% |
| 2017 | -$760K | N/A |
Comparison INmune Bio (INMB) five years free cash flow CAGR with competitors
INmune Bio (INMB) five years free cash flow CAGR is 9.22%.